Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: Neurosci Biobehav Rev. 2019 Jan 4;98:85–94. doi: 10.1016/j.neubiorev.2018.12.030

Table 1a.

Characteristics of Samples Included in Bilateral Structure Analyses

Schizophrenia
Controls
Characteristic N Mean Across Samples SD Across Samples N Mean Across Samples SD Across Samples
Group Size 219 34.94 27.23 219 36.68 31.60
Age 204
(201)
30.74
(7.20)
8.27
(2.97)
204
(201)
30.39
(7.15)
8.53
(3.28)
Sex 216 66.74 28.60 216 64.17 28.96
Handedness 138 92.76 9.42 137 94.35 7.55
Ethnicity 32 70.94 26.07 32 76.03 21.84
Education 90
(89)
12.42
(2.48)
1.72
(0.84)
90
(89)
14.01
(2.50)
1.90
(1.12)
Socioeconomic Status 48
(48)
2.88
(1.02)
0.57
(0.39)
47
(47)
2.62
(0.92)
0.60
(0.31)
Intelligence Quotient 45
(44)
97.61
(13.68)
9.45
(3.51)
45
(44)
109.79
(11.70)
7.34
(2.84)
Height 37
(37)
170.11
(8.11)
6.82
(2.16)
37
(37)
171.59
(7.69)
7.09
(2.20)

Scanning Parameters
Magnetic Field Strength
 0.5 T 1 0.5%
 1.0 T 5 2.3%
 1.5 T 180 82.2%
 2.0 T 1 0.5%
 3.0 T 20 9.1%
Slice Thickness 181 1.59 0.83
Slice Gap Width 124 0.07 0.35
Intrarater Reliability 71 0.91 0.08
Interrater Reliability 31 0.92 0.07

Clinical Characteristics
First-Episode (%) 63 94.53 18.10
Chronic (%) 27 97.91 10.88
Inpatient (%) 10 71.94 32.77
Outpatient (%) 14 78.97 33.52
Medicated (%) 82 90.66 24.16
Antipsychotic Dosage 68
(66)
468.17
(344.97)
220.16
(174.51)
Illness Onset 94
(94)
22.64
(5.47)
3.79
(1.70)
Illness Duration 131
(129)
9.65
(6.10)
7.11
(3.56)
Symptom Severity 51
(51)
71.52
(16.53)
15.02
(5.25)

Note. Group proportions or means within samples are shown with standard deviations enclosed in parentheses where appropriate. N (number of samples reporting a given characteristic), sex (proportion male), handedness (proportion right-handed), ethnicity (proportion European ancestry), education (years of formal education), height (centimeters), socioeconomic status (parental socioeconomic status rated on the Hollingshead Index), antipsychotic dosage (daily dosage in chlorpromazine equivalents only for antipsychotic exposed samples), illness onset (age at schizophrenia onset), symptom severity (Positive and Negative Symptom Scale overall score).